Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 01.10.2020
Ina Invest Holding AG
Ina Invest generates initial rental income of more than CHF 2 million per year through portfolio expansion. Acquired properties are perfect strategic fit and underline successful collaboration with Implenia. Acquisition target for 2020 already exceeded.
Zurich, 1 October 2020 - Ina Invest today signed contracts to purchase two existing properties [ … ]
Thu, 01.10.2020
TubeSolar AG
Adhoc-Release
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
TubeSolar AG plans capital increase with subscription rights and aims for listing on primary market of Dusseldorf Stock Exchange and m:access o [ … ]
Wed, 30.09.2020
Bayer Aktiengesellschaft
Leverkusen, September 30, 2020 - Bayer AG announced today that the company confirms its adjusted outlook for 2020 and expects 2021 sales at approximately 2020 levels despite significant headwinds from the COVID-19 pandemic, especially in the agricultural market. Core earnings per share in 2021 are expected to be slightly below 2020 levels at consta [ … ]
Wed, 30.09.2020
First Sensor AG
Ad-hoc announcement / Inside information according to Art. 17 MAR
First Sensor AG
Peter-Behrens-Str. 15
12459 Berlin, Germany
First Sensor Share:
ISIN DE0007201907 Ι WKN (German Securities Identification Number) 720190
Berlin, September 30, 2020The Chairman of the Supervisory Board has resigned
The Chairman of the Supervisory Board, John Mitchel [ … ]
Wed, 30.09.2020
SHOP APOTHEKE EUROPE N.V.
NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW.
SHOP APOTHEKE EUROPE N.V. ANNOUNCES UPDATE ON DISCUSSIONS ABOUT ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2 [ … ]
Wed, 30.09.2020
GN Store Nord A/S
GN Store Nord announces that Marcus Desimoni, our CFO for the past five years, will be leaving GN as of December 31, 2020. He will step down from his dual position as CFO of GN Store Nord and of GN Hearing. He will remain active within GN as part of the company's Strategy Committee.
Peter la Cour Gormsen, currently CFO of GN Audio, is appointed CFO [ … ]
Wed, 30.09.2020
Fielmann AG
Our business performance continued to recover in the third quarter of 2020 thanks to the consistent application of our hygiene standards.
According to preliminary estimates, Fielmann generated consolidated sales of approximately € 420 million (previous year: € 400.0 million) and pre-tax profits of around € 80 million (previous year: € 78.5 millio [ … ]
Wed, 30.09.2020
Covestro AG
September 30, 2020 - Covestro today has signed an agreement to acquire the Resins & Functional Materials business (RFM) from Royal DSM. Through this transaction, Covestro is taking a significant step in its long-term corporate strategy to strengthen its sustainable and innovation-driven businesses. The integration of RFM will add about EUR 1 bi [ … ]
Wed, 30.09.2020
Conzzeta
Bystronic takes full control of DNE Laser
Enhanced flexibility to deploy growth strategy
Zurich, September 30, 2020 - As part of the growth strategy for its Bystronic business unit, Conzzeta announces the signing of an equity transfer agreement to increase the participation in DNE Laser, Shenzhen, China, from 70% to 100%.
With the acquisition of [ … ]
Tue, 29.09.2020
Merck KGaA
Darmstadt, September 29, 2020. In the United States Merck KGaA's subsidiary EMD Serono, Inc. (Merck) is involved in a US patent dispute with Biogen Inc., United States (Biogen). Biogen sued Merck for damages in connection with a patent infringement caused by Merck's product Rebif before the U.S. District Court New Jersey, Newark. Merck defended its [ … ]